RET融合转移性结肠癌对塞尔珀卡提尼布有反应-一个病例报告
William J Mullally1, Michael Huo2, Kenneth J O'Byrne1,3,4
1Department of Medical Oncology, Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD 4102, Australia.
Oxford medical case reports
|July 28, 2025
概括
一名患有结肠癌脑转移的患者有一个罕见的NCOA4-RET融合,通过整个外体序列测序 (WES) 检测到. 使用塞尔珀卡提尼布的向治疗显示出有效性,突出显示了罕见突变分子分析的价值.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 神经瘤学神经瘤学
背景情况:
- 结肠癌可以转移到大脑,从而带来复杂的治疗挑战.
- 辅助化疗是标准的,但复发需要进一步的治疗策略.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.2K
相关概念视频
02:57Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
02:56Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K